A Study to Evaluate EDG-7500 in People With Renal Impairment

NCT07034768 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
37
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Edgewise Therapeutics, Inc.